HEADER VIRAL PROTEIN/VIRAL PROTEIN INHIBITOR 29-AUG-07 2R3C TITLE STRUCTURE OF THE GP41 N-PEPTIDE IN COMPLEX WITH THE HIV ENTRY TITLE 2 INHIBITOR PIE1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GP41 N-PEPTIDE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HIV ENTRY INHIBITOR PIE1; COMPND 7 CHAIN: C, D; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 OTHER_DETAILS: PEPTIDE SYNTHESIS; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 9 ORGANISM_TAXID: 32630; SOURCE 10 OTHER_DETAILS: PEPTIDE SYNTHESIS KEYWDS HIV, INHIBITOR, VIRAL ENTRY, PIE, VIRAL PROTEIN, VIRAL PROTEIN-VIRAL KEYWDS 2 PROTEIN INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.P.VANDEMARK,B.WELCH,A.HEROUX,C.P.HILL,M.S.KAY REVDAT 8 08-AUG-18 2R3C 1 DBREF LINK REVDAT 7 25-OCT-17 2R3C 1 SOURCE REMARK REVDAT 6 15-FEB-12 2R3C 1 DBREF SEQADV SEQRES REVDAT 5 13-JUL-11 2R3C 1 VERSN REVDAT 4 24-FEB-09 2R3C 1 VERSN REVDAT 3 06-NOV-07 2R3C 1 JRNL REVDAT 2 30-OCT-07 2R3C 1 JRNL REVDAT 1 02-OCT-07 2R3C 0 JRNL AUTH B.D.WELCH,A.P.VANDEMARK,A.HEROUX,C.P.HILL,M.S.KAY JRNL TITL POTENT D-PEPTIDE INHIBITORS OF HIV-1 ENTRY JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 16828 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17942675 JRNL DOI 10.1073/PNAS.0708109104 REMARK 2 REMARK 2 RESOLUTION. 1.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 32413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : SELECTED RANDOMLY WITH EQUAL REMARK 3 NUMBERS IN EACH RESOLUTION REMARK 3 BIN. TOTAL NUMBER OF REMARK 3 REFLECTIONS TO EXCEED 1500. REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1510 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 962 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.19200 REMARK 3 B22 (A**2) : -5.19200 REMARK 3 B33 (A**2) : 10.38500 REMARK 3 B12 (A**2) : -3.30900 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.107 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.782 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.341 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.676 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 53.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_WCAPS.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DATA HAS A TWIN FRACTION OF 0.326 REMARK 4 REMARK 4 2R3C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-SEP-07. REMARK 100 THE DEPOSITION ID IS D_1000044372. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X26C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07274 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33506 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.730 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.09400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27% PEG 2000 MME, 0.1M SODIUM ACETATE, REMARK 280 0.4M YCL3, PH 4.6, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 68.53950 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 68.53950 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 68.53950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -88.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -103.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 46.84300 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 23.42150 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 40.56723 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 Y YT3 A 502 LIES ON A SPECIAL POSITION. REMARK 375 CL CL A 503 LIES ON A SPECIAL POSITION. REMARK 375 Y YT3 B 102 LIES ON A SPECIAL POSITION. REMARK 375 Y YT3 B 103 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE HIV ENTRY INHIBITOR PIE1 IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: HIV ENTRY INHIBITOR PIE1 REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ACE B 0 REMARK 465 ARG B 1 REMARK 465 MET B 2 REMARK 465 LYS B 3 REMARK 465 ACE C 0 REMARK 465 DLY C 1 REMARK 465 DLY C 2 REMARK 465 ACE D 0 REMARK 465 DLY D 1 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 YT3 A 501 Y REMARK 620 N RES CSSEQI ATOM REMARK 620 1 DGL C 9 OE2 REMARK 620 2 GLU A 10 OE2 114.5 REMARK 620 3 GLU A 10 OE1 71.4 53.0 REMARK 620 4 DGL C 9 OE1 52.6 86.2 83.0 REMARK 620 5 ASP A 7 OD2 157.1 76.2 104.1 150.4 REMARK 620 6 HOH C 113 O 79.9 117.0 80.8 132.5 77.1 REMARK 620 7 HOH C 107 O 77.1 162.3 144.0 91.4 98.2 77.1 REMARK 620 8 HOH A 633 O 132.1 71.8 123.5 82.3 69.7 142.5 90.5 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 YT3 B 101 Y REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 7 OD1 REMARK 620 2 DGL D 9 OE2 154.5 REMARK 620 3 HOH B 222 O 70.3 134.2 REMARK 620 4 DGL D 9 OE1 149.3 55.4 83.7 REMARK 620 5 GLU B 10 OE1 79.3 110.5 76.0 78.6 REMARK 620 6 HOH B 206 O 92.6 89.2 74.1 95.9 150.0 REMARK 620 7 HOH D 112 O 85.1 69.3 150.9 123.8 115.5 92.3 REMARK 620 8 GLU B 10 OE2 98.0 73.6 126.5 84.1 50.5 159.1 70.9 REMARK 620 N 1 2 3 4 5 6 7 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YT3 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YT3 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YT3 B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YT3 B 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YT3 B 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF HIV ENTRY INHIBITOR REMARK 800 PIE1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF HIV ENTRY INHIBITOR REMARK 800 PIE1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2R5B RELATED DB: PDB REMARK 900 RELATED ID: 2R5D RELATED DB: PDB DBREF 2R3C A 1 45 PDB 2R3C 2R3C 1 45 DBREF 2R3C B 1 45 PDB 2R3C 2R3C 1 45 DBREF 2R3C C 0 17 PDB 2R3C 2R3C 0 17 DBREF 2R3C D 0 17 PDB 2R3C 2R3C 0 17 SEQADV 2R3C ACE A 0 PDB 2R3C ACETYLATION SEQADV 2R3C NH2 A 46 PDB 2R3C AMIDATION SEQADV 2R3C ACE B 0 PDB 2R3C ACETYLATION SEQADV 2R3C NH2 B 46 PDB 2R3C AMIDATION SEQRES 1 A 47 ACE ARG MET LYS GLN ILE GLU ASP LYS ILE GLU GLU ILE SEQRES 2 A 47 GLU SER LYS GLN LYS LYS ILE GLU ASN GLU ILE ALA ARG SEQRES 3 A 47 ILE LYS LYS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 A 47 GLN LEU GLN ALA ARG ILE LEU NH2 SEQRES 1 B 47 ACE ARG MET LYS GLN ILE GLU ASP LYS ILE GLU GLU ILE SEQRES 2 B 47 GLU SER LYS GLN LYS LYS ILE GLU ASN GLU ILE ALA ARG SEQRES 3 B 47 ILE LYS LYS LEU LEU GLN LEU THR VAL TRP GLY ILE LYS SEQRES 4 B 47 GLN LEU GLN ALA ARG ILE LEU NH2 SEQRES 1 C 18 ACE DLY DLY GLY DAL DCY DGL DSN DPR DGL DTR DGN DTR SEQRES 2 C 18 DLE DCY DAL DAL NH2 SEQRES 1 D 18 ACE DLY DLY GLY DAL DCY DGL DSN DPR DGL DTR DGN DTR SEQRES 2 D 18 DLE DCY DAL DAL NH2 HET ACE A 0 3 HET NH2 A 46 1 HET NH2 B 46 1 HET DAL C 4 5 HET DCY C 5 6 HET DGL C 6 9 HET DSN C 7 6 HET DPR C 8 7 HET DGL C 9 9 HET DTR C 10 14 HET DGN C 11 9 HET DTR C 12 14 HET DLE C 13 8 HET DCY C 14 6 HET DAL C 15 5 HET DAL C 16 5 HET NH2 C 17 1 HET DLY D 2 9 HET DAL D 4 5 HET DCY D 5 6 HET DGL D 6 9 HET DSN D 7 6 HET DPR D 8 7 HET DGL D 9 9 HET DTR D 10 14 HET DGN D 11 9 HET DTR D 12 14 HET DLE D 13 8 HET DCY D 14 6 HET DAL D 15 5 HET DAL D 16 5 HET NH2 D 17 1 HET YT3 A 501 1 HET YT3 A 502 1 HET CL A 503 1 HET YT3 B 101 1 HET YT3 B 102 1 HET YT3 B 103 1 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP HETNAM DAL D-ALANINE HETNAM DCY D-CYSTEINE HETNAM DGL D-GLUTAMIC ACID HETNAM DSN D-SERINE HETNAM DPR D-PROLINE HETNAM DTR D-TRYPTOPHAN HETNAM DGN D-GLUTAMINE HETNAM DLE D-LEUCINE HETNAM DLY D-LYSINE HETNAM YT3 YTTRIUM (III) ION HETNAM CL CHLORIDE ION FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 4(H2 N) FORMUL 3 DAL 6(C3 H7 N O2) FORMUL 3 DCY 4(C3 H7 N O2 S) FORMUL 3 DGL 4(C5 H9 N O4) FORMUL 3 DSN 2(C3 H7 N O3) FORMUL 3 DPR 2(C5 H9 N O2) FORMUL 3 DTR 4(C11 H12 N2 O2) FORMUL 3 DGN 2(C5 H10 N2 O3) FORMUL 3 DLE 2(C6 H13 N O2) FORMUL 4 DLY C6 H14 N2 O2 FORMUL 5 YT3 5(Y 3+) FORMUL 7 CL CL 1- FORMUL 11 HOH *210(H2 O) HELIX 1 1 ARG A 1 LEU A 45 1 45 HELIX 2 2 GLN B 4 LEU B 45 1 42 HELIX 3 3 GLY C 3 DSN C 7 5 5 HELIX 4 4 DTR C 10 DAL C 16 1 7 HELIX 5 5 GLY D 3 DGL D 9 5 7 HELIX 6 6 DTR D 10 DAL D 16 1 7 SSBOND 1 DCY C 5 DCY C 14 1555 1555 2.04 SSBOND 2 DCY D 5 DCY D 14 1555 1555 2.04 LINK C DAL C 16 N NH2 C 17 1555 1555 1.33 LINK C LEU A 45 N NH2 A 46 1555 1555 1.33 LINK C LEU B 45 N NH2 B 46 1555 1555 1.33 LINK C DAL D 16 N NH2 D 17 1555 1555 1.33 LINK N ARG A 1 C ACE A 0 1555 1555 1.33 LINK C GLY C 3 N DAL C 4 1555 1555 1.33 LINK C DAL C 4 N DCY C 5 1555 1555 1.33 LINK C DCY C 5 N DGL C 6 1555 1555 1.34 LINK SG DCY C 5 SG DCY C 14 1555 1555 2.04 LINK C DGL C 6 N DSN C 7 1555 1555 1.33 LINK C DSN C 7 N DPR C 8 1555 1555 1.37 LINK C DPR C 8 N DGL C 9 1555 1555 1.34 LINK C DGL C 9 N DTR C 10 1555 1555 1.34 LINK C DTR C 10 N DGN C 11 1555 1555 1.33 LINK C DGN C 11 N DTR C 12 1555 1555 1.34 LINK C DTR C 12 N DLE C 13 1555 1555 1.34 LINK C DLE C 13 N DCY C 14 1555 1555 1.34 LINK C DCY C 14 N DAL C 15 1555 1555 1.34 LINK C DAL C 15 N DAL C 16 1555 1555 1.33 LINK C DLY D 2 N GLY D 3 1555 1555 1.33 LINK C GLY D 3 N DAL D 4 1555 1555 1.34 LINK C DAL D 4 N DCY D 5 1555 1555 1.33 LINK SG DCY D 5 SG DCY D 14 1555 1555 2.04 LINK C DCY D 5 N DGL D 6 1555 1555 1.33 LINK C DGL D 6 N DSN D 7 1555 1555 1.33 LINK C DSN D 7 N DPR D 8 1555 1555 1.36 LINK C DPR D 8 N DGL D 9 1555 1555 1.34 LINK C DGL D 9 N DTR D 10 1555 1555 1.33 LINK C DTR D 10 N DGN D 11 1555 1555 1.33 LINK C DGN D 11 N DTR D 12 1555 1555 1.34 LINK C DTR D 12 N DLE D 13 1555 1555 1.34 LINK C DLE D 13 N DCY D 14 1555 1555 1.33 LINK C DCY D 14 N DAL D 15 1555 1555 1.34 LINK C DAL D 15 N DAL D 16 1555 1555 1.34 LINK OE2 DGL C 9 Y YT3 A 501 1555 1555 2.41 LINK OE2 GLU A 10 Y YT3 A 501 1555 1555 2.42 LINK OE1 GLU A 10 Y YT3 A 501 1555 1555 2.51 LINK OE1 DGL C 9 Y YT3 A 501 1555 1555 2.53 LINK OD2 ASP A 7 Y YT3 A 501 1555 1555 2.78 LINK OD1 ASP B 7 Y YT3 B 101 1555 1555 2.10 LINK OE2 DGL D 9 Y YT3 B 101 1555 1555 2.30 LINK Y YT3 B 101 O HOH B 222 1555 1555 2.30 LINK Y YT3 A 501 O HOH C 113 1555 1555 2.35 LINK OE1 DGL D 9 Y YT3 B 101 1555 1555 2.40 LINK OE1 GLU B 10 Y YT3 B 101 1555 1555 2.42 LINK Y YT3 B 101 O HOH B 206 1555 1555 2.45 LINK Y YT3 A 501 O HOH C 107 1555 1555 2.53 LINK Y YT3 A 501 O HOH A 633 1555 1555 2.54 LINK Y YT3 B 101 O HOH D 112 1555 1555 2.68 LINK OE2 GLU B 10 Y YT3 B 101 1555 1555 2.71 LINK OG1 THR B 33 Y YT3 B 103 1555 1555 2.82 LINK NE2 GLN B 16 Y YT3 B 102 1555 1555 3.16 LINK OE1 GLN A 16 Y YT3 A 502 1555 1555 3.43 SITE 1 AC1 4 ASP A 7 GLU A 10 HOH A 635 DGL C 9 SITE 1 AC2 1 GLN A 16 SITE 1 AC3 1 THR A 33 SITE 1 AC4 3 ASP B 7 GLU B 10 DGL D 9 SITE 1 AC5 1 GLN B 16 SITE 1 AC6 2 LEU B 30 THR B 33 SITE 1 AC7 15 GLU A 10 GLU A 13 SER A 14 LYS A 17 SITE 2 AC7 15 ASN A 21 YT3 A 501 HOH A 632 LEU B 29 SITE 3 AC7 15 LEU B 32 VAL B 34 TRP B 35 GLY B 36 SITE 4 AC7 15 LYS B 38 GLN B 41 LEU B 45 SITE 1 AC8 13 LEU A 29 LEU A 32 VAL A 34 TRP A 35 SITE 2 AC8 13 GLY A 36 ILE A 37 LYS A 38 GLN A 41 SITE 3 AC8 13 GLU B 10 GLU B 13 SER B 14 LYS B 17 SITE 4 AC8 13 ASN B 21 CRYST1 46.843 46.843 137.079 90.00 90.00 120.00 P 63 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021348 0.012325 0.000000 0.00000 SCALE2 0.000000 0.024650 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007295 0.00000 HETATM 1 C ACE A 0 7.663 -2.264 20.452 1.00 30.84 C HETATM 2 O ACE A 0 8.218 -2.074 19.372 1.00 30.68 O HETATM 3 CH3 ACE A 0 8.338 -1.867 21.734 1.00 30.07 C